ARTRX
Price
$34.63
Change
+$0.33 (+0.96%)
Updated
Sep 4 closing price
Net Assets
2.11B
RNPCX
Price
$69.39
Change
+$0.32 (+0.46%)
Updated
Sep 5 closing price
Net Assets
159.21B
Interact to see
Advertisement

ARTRX vs RNPCX

Header iconARTRX vs RNPCX Comparison
Open Charts ARTRX vs RNPCXBanner chart's image
Artisan Global Opportunities I
Price$34.63
Change+$0.33 (+0.96%)
VolumeN/A
Net Assets2.11B
American Funds New Perspective R3
Price$69.39
Change+$0.32 (+0.46%)
VolumeN/A
Net Assets159.21B
ARTRX vs RNPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARTRX vs. RNPCX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTRX is a Hold and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 159B vs. ARTRX (2.11B). RNPCX pays higher dividends than ARTRX: RNPCX (0.22) vs ARTRX (0.00). ARTRX was incepted earlier than RNPCX: ARTRX (17 years) vs RNPCX (23 years). ARTRX (1.19) is less costly to investors than RNPCX (1.06). ARTRX is a more actively managed with annual turnover of: 52.39 vs. RNPCX (24.00). RNPCX has a lower initial minimum investment than ARTRX: RNPCX (250) vs ARTRX (1000). RNPCX annual gain was more profitable for investors over the last year : 14.64 vs. ARTRX (0.81). RNPCX return over 5 years is better than : 33.04 vs. ARTRX (1.82).
ARTRXRNPCXARTRX / RNPCX
Total Expense Ratio1.191.06112%
Annual Report Gross Expense Ratio1.191.06112%
Fund Existence17 years23 years-
Gain YTD9.48315.51561%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B159B1%
Annual Yield % from dividends0.000.22-
Returns for 1 year0.8114.646%
Returns for 3 years30.5947.3865%
Returns for 5 years1.8233.045%
Returns for 10 years84.1394.4189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UEPIX17.690.16
+0.91%
ProFunds Europe 30 Inv
SAGAX59.360.32
+0.54%
Virtus Zevenbergen Innovative Gr Stk A
PESPX30.030.15
+0.50%
BNY Mellon MidCap Index Inv
FCSDX17.840.03
+0.17%
Fidelity Advisor Strategic Div & Inc C
CGEOX20.04-0.03
-0.15%
Calamos Global Equity R6